Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Transgêneros buscam procedimentos estéticos injetáveis na luta por autorreconhecimento


News provided by

Galderma

Sep 11, 2023, 10:42 ET

Share this article

Share toX

Share this article

Share toX

Na procura por redesignação facial, tratamento com ácido hialurônico injetável tem sido opção buscada por pessoas trans

SÃO PAULO, 11 de setembro de 2023 /PRNewswire/ -- A procura por adequar o corpo à identidade de gênero não se limita apenas ao aumento da autoestima. Para pessoas trans, essa adequação está intimamente ligada à qualidade de vida, reconhecimento e identificação com quem se é. Segundo uma pesquisa realizada pela Faculdade de Medicina de Botucatu da Universidade Estadual Paulista (FMB/Unesp), cerca de 1,9% da população adulta brasileira, aproximadamente 4 milhões de pessoas, são transgênero ou não-binárias1. Muitas delas se encontram em uma jornada de descoberta de seus corpos, buscando traços que marquem a distinção de seu gênero.

Continue Reading

Procedimentos estéticos com ácido hialurônico injetável podem ser uma opção para alcançar resultados desejados sem métodos muito invasivos, recuperação prolongada, dor intensa ou altos custos.

O médico dermatologista Dr. Walter Loureiro (CRM-PA 10995), experiente em realizar procedimentos em pessoas transgêneros, explica que, muitas das vezes, é mais vantagem realizar procedimentos estéticos injetáveis ao invés de cirurgias plásticas. "Os procedimentos estéticos injetáveis são uma opção segura, eficaz e menos invasiva quando comparada a uma cirurgia, por exemplo. Seus resultados são notados mais rapidamente, com uma recuperação pós procedimento mais tranquila", destaca.

Pacientes celebram procedimentos seguros e resultados imediatos

A influenciadora Gabi Kassab, que passou pelo processo de transição, conta como foi sua experiência ao realizar procedimentos estéticos injetáveis para estar de acordo com o visual que sempre desejou. Ela explica que, ao entender que poderia alcançar os resultados desejados e feminizar seu rosto com ácido hialurônico, conseguiu se libertar de outros procedimentos que a faziam mal.

Gabi utilizou Restylane® para realçar as maçãs da face, suavizar os traços do contorno da mandíbula e afinar o rosto. "Hoje eu encontrei a minha beleza e sou muito mais feliz por me olhar no espelho e reconhecer a mulher que sou. Essa experiência me possibilitou a oportunidade de alcançar meus objetivos individuais em relação ao meu rosto e a me tornar ainda mais eu", comemora.

Além dos procedimentos realizados por ela, outro bem comum entre mulheres trans, de acordo com o Dr. Walter, é a valorização dos lábios com a ajuda de ácido hialurônico injetável específico para essa região, como Restylane® KysseTM. No caso de homens trans, ainda segundo a experiência do dermatologista, a região que mais procuram tratar é a do terço inferior do rosto, já que a mandíbula é uma das regiões que mais marcam a distinção entre homens e mulheres. "Eles buscam deixar esses traços mais retos e marcados, com o queixo mais largo e o ângulo da mandíbula mais fechado", diz Dr. Walter Loureiro.

Para todos esses casos, Restylane®, a linha de ácido hialurônico injetável mais completa2 e segura do mercado3, conta com diferentes tipos de géis de ácido hialurônico indicados para necessidades e regiões faciais distintas, como definir o contorno facial4 e labial5, projetar áreas faciais, como mandíbula e queixo4 e realçar as maçãs do rosto6. A durabilidade desses procedimentos é de até 12 meses7.

"Com ácido hialurônico injetável, 80% do resultado final já é perceptível logo após o procedimento e os outros 20% são perceptíveis com cerca de duas semanas", explica o dermatologista.

A aplicação de Restylane® deve ser feita por um profissional de saúde habilitado à prática de estética injetável. Para mais informações, acesse www.galdermaaesthetics.com.br/tipos-de-restylane

1Escola Politécnica de Saúde Joaquim Venâncio. Fiocruz. Um (longo) caminho para a saúde universal. Acesso em 14 de julho de 2023 em https://www.epsjv.fiocruz.br/sites/default/files/poli_87_web.pdf

2Rzany B., Bayerl C., Bodokh I. et al. Eficacy and safety of a new hyaluronic acid dermal filler in the treatment of
moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison
study. J Cosmet Laser Ther 2011;13:107-112.

3Sadeghpour M, et al. Delayed-Onset Nodules to Differentially Crosslinked Hyaluronic Acids: comparative Incidence
and Risk Assessment. Dermatol Surg 2019;45:1085–1094.

4Rzany B., Cartier H., Kestemont P. et al. Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid llers. J Drugs Dermatol. 2012; 2(1) (Suppl):s27-34.

5Hilton S, Sattler G, Berg AK, et al. Randomized, Evaluator-Blinded Study Comparing Safety and Effect of Two Hyaluronic Acid Gels for Lips Enhancement.Dermatol Surg. 2018;44(2):261-269.

6Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012 Jul 1;4(3):253-8.

7Gubanova EI et al. J Drugs Dermatol 2015.

Sobre Restylane®
Restylane® é a linha de ácido hialurônico original com mais de 26 anos de conquistas e mais de 55 milhões de tratamentos realizados em todo o mundo*. As tecnologias NASHATM e OBTTM fazem de Restylane® a linha mais diversificada de ácido hialurônico injetável do mundo para fornecer resultados verdadeiramente individualizados. O portfólio de produtos Restylane® inclui Restylane® LyftTM, Restylane® DefyneTM, Restylane® RefyneTM, Restylane® KysseTM, Restylane® VolymeTM e Restylane® SkinboostersTM Vital e Vital Light. Para saber mais, acesse:
https://www.galdermaaesthetics.com.br/tipos-de-restylane
*Data on file, MA-39680.

Sobre a Galderma
A Galderma é a empresa líder na categoria dedicada ao avanço de soluções para o cuidado da pele, presente em aproximadamente 90 países. Fornecemos um portfólio inovador e baseado em ciência de marcas e serviços premium que abrangem todo o espectro de dermatologia em rápido crescimento por meio de Estética Injetável, Skincare Dermatológico e Dermatologia Terapêutica. Desde nossa fundação em 1981, dedicamos nosso foco e paixão ao maior órgão do corpo humano – a pele – atendendo às necessidades individuais de consumidores e pacientes com resultados superiores em parceria com profissionais de saúde. Estamos avançando a dermatologia para cada história de pele, porque entendemos que a pele em que estamos molda nossas histórias de vida. O portfólio de marcas emblemáticas da Galderma inclui Restylane® e Sculptra® em Estética Injetável; Cetaphil, Dermotivin e Benzac em Skincare Dermatológico; além dos medicamentos prescritos para Acne e Rosácea em Dermatologia Terapêutica. Para mais informações: www.galderma.com/br e galdermaaesthetics.com.br

Foto - https://mma.prnewswire.com/media/2206952/Gabi_Kassab.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Retail

Retail

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.